Continuous Renal Replacement Therapy for Treatment of Severe Attacks of Inborn Errors of Metabolism

Abstract

Severe metabolic crises in children with inborn errors of metabolism can result in mortality or severe morbidities where continuous renal replacement therapy (CRRT) can be lifesaving. Clinical data, the pediatric risk of mortality (PRISM) scores calculated in the first 24 hours, and pediatric logistic organ dysfunction (PELOD) scores calculated in the last 24 hours before CRRT, were studied. Overall, CRRT was successful in restoring metabolic balance in 72% of patients. PELOD scores before CRRT were lower in survivors (p = 0.02). Despite numerous comorbid factors, CRRT can be used effectively in management of metabolic crises. Early intervention with this therapy before occurrence of complications must be targeted.

Keywords

continuous renal replacement therapy - inborn errors of metabolism - acute metabolic crises

Note

The work was conducted in Hacettepe University Faculty of Medicine, Pediatric Intensive Care Unit; Dr Sami Ulus Maternity and Children's Training and Research Hospital, Pediatric Intensive Care Unit and Ankara Children's Hematology; and Oncology Training and Research Hospital, Pediatric Intensive Care Unit, Ankara, Turkey.

• References

• 1 Lai YC, Huang HP, Tsai IJ, Tsau YK. High-volume continuous venovenous hemofiltration as an effective therapy for acute management of inborn errors of metabolism in young children. Blood Purif 2007; 25 (04) 303-308
• 2 Arbeiter AK, Kranz B, Wingen AM. , et al. Continuous venovenous haemodialysis (CVVHD) and continuous peritoneal dialysis (CPD) in the acute management of 21 children with inborn errors of metabolism. Nephrol Dial Transplant 2010; 25 (04) 1257-1265
• 3 Tsai IJ, Hwu WL, Huang SC. , et al. Efficacy and safety of intermittent hemodialysis in infants and young children with inborn errors of metabolism. Pediatr Nephrol 2014; 29 (01) 111-116
• 4 Chen CY, Tsai TC, Lee WJ, Chen HC. Continuous hemodiafiltration in the treatment of hyperammonemia due to methylmalonic acidemia. Ren Fail 2007; 29 (06) 751-754
• 5 Schaefer F, Straube E, Oh J, Mehls O, Mayatepek E. Dialysis in neonates with inborn errors of metabolism. Nephrol Dial Transplant 1999; 14 (04) 910-918
• 6 Picca S, Dionisi-Vici C, Bartuli A. , et al. Short-term survival of hyperammonemic neonates treated with dialysis. Pediatr Nephrol 2015; 30 (05) 839-847
• 7 Picca S, Dionisi-Vici C, Abeni D. , et al. Extracorporeal dialysis in neonatal hyperammonemia: modalities and prognostic indicators. Pediatr Nephrol 2001; 16 (11) 862-867
• 8 McBryde KD, Kershaw DB, Bunchman TE. , et al. Renal replacement therapy in the treatment of confirmed or suspected inborn errors of metabolism. J Pediatr 2006; 148 (06) 770-778
• 9 Thompson GN, Butt WW, Shann FA. , et al. Continuous venovenous hemofiltration in the management of acute decompensation in inborn errors of metabolism. J Pediatr 1991; 118 (06) 879-884
• 10 Hanudel M, Avasare S, Tsai E, Yadin O, Zaritsky J. A biphasic dialytic strategy for the treatment of neonatal hyperammonemia. Pediatr Nephrol 2014; 29 (02) 315-320
• 11 Brismar J, Ozand PTCT. CT and MR of the brain in the diagnosis of organic acidemias. Experiences from 107 patients. Brain Dev 1994; 16 (Suppl): 104-124
• 12 Radmanesh A, Zaman T, Ghanaati H, Molaei S, Robertson RL, Zamani AA. Methylmalonic acidemia: brain imaging findings in 52 children and a review of the literature. Pediatr Radiol 2008; 38 (10) 1054-1061
• 13 Ozand PT, Rashed M, Gascon GG. , et al. Unusual presentations of propionic acidemia. Brain Dev 1994; 16 (Suppl): 46-57
• 14 Thimm E, Hadzik B, Höhn T. Continuous venovenous hemofiltration rapidly lowers toxic metabolites in a patient with MSUD and imminent cerebral herniation. Klin Padiatr 2010; 222 (04) 264-265
• 15 Duval M, Fenneteau O, Doireau V. , et al. Intermittent hemophagocytic lymphohistiocytosis is a regular feature of lysinuric protein intolerance. J Pediatr 1999; 134 (02) 236-239
• 16 Stork LC, Ambruso DR, Wallner SF. , et al. Pancytopenia in propionic acidemia: hematologic evaluation and studies of hematopoiesis in vitro. Pediatr Res 1986; 20 (08) 783-788
• 17 Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Eur J Pediatr 2007; 166 (02) 95-109
• 18 Dellinger RP, Levy MM, Rhodes A. , et al; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41 (02) 580-637
• 19 Westrope C, Morris K, Burford D, Morrison G. Continuous hemofiltration in the control of neonatal hyperammonemia: a 10-year experience. Pediatr Nephrol 2010; 25 (09) 1725-1730
• 20 Foland JA, Fortenberry JD, Warshaw BL. , et al. Fluid overload before continuous hemofiltration and survival in critically ill children: a retrospective analysis. Crit Care Med 2004; 32 (08) 1771-1776
• 21 Guerra-Moreno J, Barrios N, Santiago-Borrero PJ. Severe neutropenia in an infant with methylmalonic acidemia. Bol Asoc Med P R 2003; 95 (01) 17-20